Embed Size (px)
Citation preview
©2019Axendia,Inc.
TRUSTED ADVICE. TRUSTED SOURCES.
/
MORETHANSKINDEEP:DASSAULTSYSTÈMESISTRANSFORMINGTHEPATIENTEXPERIENCE
DASSAULTSYSTÈMES3DEXPERIENCENORTHAMERICAFORUMEVENTBRIEFBy:DanielR.Matlis,President INTRODUCTION Atthisyear’s3DEXPERIENCENorthAmericaForum,DassaultSystèmescontinuedtodemonstrateitscommitmenttotransformingthepatientexperience.UndertheleadershipofBernardCharlès,ViceChairman,ChiefExecutiveOfficer,thecompanycontinuestosubstantiallydeliveronthepromise:“toenableinnovativepatientexperiencesthroughaHolisticPatient-Centricstrategy.”(Read:DassaultTargetsLife-ScienceswithMind,BodyandSoul)CharlèshasinstilledinDassaultSystèmesaculturefocusedonlongtermaudaciousgoals,drivenbyunbridledpassion,yetmeasuredbymeticulousexecution,focusedontransformingthepatientexperience.AccordingtoCharlès,“DassaultSystèmesisacompanywithalongtermmentalityfocusedonthesuccessofitscustomers.Weareaboutcreatingdifferentiatingsoftwarethatmeetstheneedsofitsclients.”DeanMarsh,ManagingDirectorNA,remarkedonthe“IndustryRenaissance”:Embracethefutureorgetleftbehind!Theattractionofsimulationisthatitletsyoutrythingswithoutthefearoffailure!AccordingtoCharlèsthereareseveralconcurrentthemesthatareimpactingtheLifeScienceindustrywithBioscienceplayingamajorrole.
Healthcareisexpensive Healthcareneedstobemoreinclusive Life-Scienceproductdevelopmentneedstotakeadvantageoftechnologicalchanges.
“DassaultSystèmesisinvestingmassivelyinLifeSciencestotransformthepatientexperiencewithacultureofsustainableinnovationandtheuseofcuttingedgetechnology,”addedCharlesAtthe3DExperienceForum,thecompanyonceagaindeliveredontheirvisionwiththeintroductionofIASO,anoncologytreatmentconceptthatcontainsaremovablepatchthatattachestothepatient’sskintodeliverabiologicsolution,dosedthroughaconnected,wearableandreusabledevice.IASOaimstoshowcasehowDassaultSystèmes3DEXPERIENCEplatformenablesitscustomerstotransformthepatientexperiencewithinnovativesolutionsthatcombinemanytechnologiestosafelyshiftthepointofcarefromtheclinic…tothepatient’shome.
©2019Axendia,Inc.2
DASSAULTSYSTÈMES3DEXPERIENCENORTHAMERICAFORUMEVENTBRIEF
IASO – TRANSFORMING PATIENCE EXPERIENCE “NamedaftertheGreekgoddessofrecovery,IASOisashowcaseforthelifecycleofacombinationproductinoncology”,saidStanleyPiper,LifeSciencesIndustrySolutionExperienceDirectoratDassaultSystèmes.“Fromupstreamthinkingthroughcommercialization,IASOdemonstratesthevaluethatDassaultSystèmesandthe3DEXPERIENCEcandelivertostakeholderschallengedwithbringinginnovationtomarketintheformofcombinationproductsandtransformingthepatientexperience.”TheIASOshowcasefeatures:
COLLABORATIVEDESIGN…deliveringmarketandcompetitiveintelligence,toprototypingandvalidation
THERAPEUTICSDESIGN&DEVELOPMENT…acceleratingdrugdesignwithunifiedpredictivescience
DEVICEDESIGN&DEVELOPMENT…leveraging3Ddesign,collaborativeengineering,andsimulation
MANUFACTURINGEXCELLENCE…reimaginingengineeringoperationsandcommercialization
ENTERPRISEOPERATIONALEXCELLENCE…featuringthe3DEXPERIENCEasaplatformtoexpediteproductinnovation,andmanageregulatoryandqualityactivities
Providingatrue360°viewoftheproduct
TheIASOprototypewascreatedbyDassaultSystèmesfordemonstrationpurposesonlyandrepresentsafictitiousproductnotsubjecttocommercialization.Formoredetailsvisit:https://ifwe.3ds.com/life-sciences/transforming-the-patient-experience-with-iaso
Source: Dassault Systèmes
©2019Axendia,Inc.3
DASSAULTSYSTÈMES3DEXPERIENCENORTHAMERICAFORUMEVENTBRIEF
InattendancewasTinaMorrison,DeputyDirectorintheDivisionofAppliedMechanicsattheFDA.TinaisthePrincipleInvestigatoronaresearchcollaborationbetweenDassaultSystèmesandtheFDA,centeredontheregulatoryscienceimpactofthecompany’sLivingHeartProject.“IASOisaneyeopeningexampleofhowmodelingandsimulationfitswithinanentiredigitallyconnectedmedicaldevicedevelopmentprocess”,saidSteveLevine,DirectorofVirtualHumanModelingandFounderoftheLivingHeartProject.“BasedonmydiscussionsattheForum,IbelievetheIASOshowcasewillservetoexpandourregulatorycollaborationtoincludeanunderstandingthefullpotentialofwhatwecallthe3DEXPERIENCETwinconcept,asawaytohelptheFDAachievetheirgoalsofprotectinghealthandsafetywhileloweringthebarrierstoinnovation”. PRESENTATIONS OF NOTE
PRINTING LIFEErikGatenholm,Co-FounderandCEOofCELLINK,wantstocreatethefutureofmedicinebydeveloping“noveltechnologiesthatallowsresearchersandscientiststocreatenewhumantissuesandorgans.”Hisvisionistoprovidethetechnologythatisalsoacosteffectivesolutiontoallowmoreresearchersaroundtheworldtogetaccessto3Dbioprinting.CELLINKisthefirstbioinkcompanyandtheleadingbioprinterproviderintheworldthatfocusesonthedevelopmentandcommercializationofbioprintingtechnologiesthatallowresearchersto3Dprinthumantissuesandorgansforthedevelopmentofpharmaceuticalandcosmetictreatments.CELLINK’sinnovativeandpatentpendingbioprintingtechnologyisabiomaterialinnovationthatenableshumancellstogrowandthriveastheywouldinthenaturalhumanbodyenvironment.Today,thecompany’sdisruptivetechnologyplatformisbeingutilizedtoprinttissuessuchascartilage,skin,liver,pancreas,andevenfullyfunctionalcancertumorsthatcanthenbeusedtodevelopnewcancertreatments.Thecompanyhas,within24months,beenabletocommercializeproductsinmorethan50
Source: CELLINK
©2019Axendia,Inc. 4
DASSAULTSYSTÈMES3DEXPERIENCENORTHAMERICAFORUMEVENTBRIEF
countriesandsoldproductstohundredsofprestigiouslabsandinstitutionsaroundtheworld,suchasHarvard,MIT,Princeton,andFDA.
ROLE AND USE OF SIMULATIONS IN DESIGNING ROBUST MEDICAL DEVICES
MilindRao,Ph.D.,StaffMechanicalEngineer,ProductDesignTeam,Dexcom,Inc.notedthatcomputersimulationsinhealthcarehavesignificantlyevolvedovertimeandisacriticalpartofmedicaldevicedesignanddevelopment.Thispresentationwalkedthroughvariousanalyticalmethodsthathavebeensuccessfullyusedtobuildrobustdevices.Dexcom,Inc.istheleaderintransformingdiabetescareandmanagementbyprovidingcontinuousglucosemonitoring(CGM)technologytohelppatientsandhealthcareprofessionalsbettermanagediabetes.
IN BRIEF LIFE-SCIENCE ORGANIZATIONS MUST TRANSFORM OR BE DISRUPTED!
DuringmyanalystkeynotesessionofferedAxendia’sperspectiveandinsightsontheimperativeforLifeSciencestoharnesspositivedisruptiontoachievepatient-centriccareintheAnalystkeynote.LifeScienceorganizationsmustharnesspositivedisruptiontoachievepatient-centriccarethatsupportsprevention,improvesoutcomesaswellasprovidingaholisticpatientexperiencethatdrivesvalue.However,toachievepatient-centriccare,Life-Scienceorganizationsmustundergodigitaltransformationthatenablesclosedloopvisibilityacrosstheproductlifecycle.Thistransformationrequirescoreparadigmshiftsincorporateculture,incentives,strategicplanning,regulatoryframeworksaswellastechnologicalsolutionsforindustrystakeholders.
Newtechnologieslikemodelingandsimulation,artificialintelligenceandtheInternetofMedicalThings(IoMT)areenablingpatient-centricmodelstoservemorepeoplearoundtheworld.Thefoundationofpatient-centriccareistheabilitytoconnecttherealanddigitalworldsthroughmulti-discipline,multi-scalemodelingandsimulation,IoMTconnecteddevices,visibilitytodatafordecisionsupportandgreatercollaboration.
Toachievepatient-centriccare,Life-Scienceorganizationsmustharnesspositivedisruptionbyimplementinganintegratedtechnologyapproachthatprovidesdigitalevidencesupportingimprovedoutcomesandvalueinaholisticexperience.
Source: Dexcom, Inc.
©2019Axendia,Inc.5
DASSAULTSYSTÈMES3DEXPERIENCENORTHAMERICAFORUMEVENTBRIEF
Atthisyear’s3DExperienceNorthAmericaForum,DassaultSystèmescontinuedtodemonstratethatitscommitmenttotransformingthepatientexperienceismorethanskindeep.Ittargetsthemind,bodyandsoul(read:DassaultTargetsLife-ScienceswithMind,BodyandSoul). ThisBriefwaswrittenbyAxendia,Inc.TheopinionsandanalysisexpressedinthisBriefreflectthejudgment of Axendia at the time of publication and are subject to change without notice.Informationcontainedinthisdocumentiscurrentasofpublicationdate. Informationcitedisnotwarranted by Axendia but has been obtained through a valid research methodology. Thisdocumentisnotintendedtoendorseanycompanyorproductandshouldnotbeattributedassuch. AboutAxendia:Axendia is a leading analyst and strategic advisory firm that focuses exclusively on the Life-Sciences markets. Since 2005, Industry stakeholders and regulators have relied on Axendia for trusted advice on Business, Regulatory and Technology issues and trends based on trusted sources. Axendia serves the entire Life-Science ecosystem ranging from start-ups to Fortune 100 companies including: Life-Science Organization, Technology & Service Providers, and Regulatory Agencies. Axendia professionals offer a unique combination of deep hands-on industry experience coupled with forward thinking insights. We contribute to our client’s success by providing long-range visibility and helping them navigate the increasingly complex landscape. Formoreinformation,[email protected]
ReadAxendia’sblog:Life-SciencePanoramaathttp://LSP.axendia.com
FollowusonTwitterattwitter.com/axendiaandLinkedInatlinkedin.com/company/axendia-inc.
©2019Axendia,Inc.AllRightsReserved.ThispublicationiscopyrightedbyAxendiaInc.andprotectedbyUnitedStatescopyrightlawsandinternationaltreaties.ThisdocumentmaynotbereproducedorpostedonanotherwebsitewithoutpriorwrittenconsentfromAxendia.Unauthorizedreproductionofthispublicationoranyportionofitbyotherpartiesmayresultinseverecivilandcriminalpenalties,andwillbeprosecutedtothemaximumextentnecessarytoprotecttherightsofthepublisher.
PublishedJuly2019
